Purpose

This study aims to examine the effects of Low-Intensity Focused Ultrasound (LIFU) on brain activity in patients with alcohol use disorder.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Male or female ≥ 18 years of age. 2. Documentation of an AUD diagnosis per DSM-5 criteria as evidenced by problematic pattern of alcohol use leading to clinically significant impairment or distress, as manifested by at least two of the DSM-5 criteria, occurring within a 12-month period. 3. Be willing to undergo a brain MRI and follow study protocol.

Exclusion Criteria

  1. Pregnant or breastfeeding. 2. Presence of a condition or abnormality that would compromise the safety of the patient or the quality of the data. 3. Non-English speaking. 4. Other investigational AUD treatments. 5. Primary psychosis, Bipolar I, or severe personality disorder. 6. Active suicidality or history of suicide attempt in the past 5 years. 7. Cognitive impairment (MoCA <24) 8. Significant medical or neurological disease, or life expectancy <12 mos. 9. Significant brain abnormality on brain imaging. 10. Any MRI exclusion criteria.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover Assignment
Intervention Model Description
This is a single-center, double-blind, controlled, randomized, complete block, 2-period crossover pilot trial.
Primary Purpose
Basic Science
Masking
Double (Participant, Outcomes Assessor)
Masking Description
Due to the objectives of the study, the identity of LIFU treatments will not be known to research staff performing the data analysis or participants.

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
VS LIFU/ VPL LIFU
Participants will be assigned to receive VS LIFU during the first LIFU treatment session.
  • Device: Low Intensity Focused Ultrasound
    An inhibitory LIFU protocol that allows suppression of neuronal activity in the basal ganglia and thalamus will be used.
    Other names:
    • LIFU
Active Comparator
VPL LIFU/VS LIFU
Participants will be assigned to receive VPL LIFU during the first LIFU treatment session.
  • Device: Low Intensity Focused Ultrasound
    An inhibitory LIFU protocol that allows suppression of neuronal activity in the basal ganglia and thalamus will be used.
    Other names:
    • LIFU

Recruiting Locations

University of California, San Francisco
San Francisco, California 94143
Contact:
Catherine Borror, BS, CCRP
415-514-6551
TN2Lab@ucsf.edu

More Details

Status
Recruiting
Sponsor
University of California, San Francisco

Study Contact

Catherine Borror, BS, CCRP
415-514-6551
TN2Lab@ucsf.edu

Detailed Description

This is a single-center, double-blind, controlled, randomized, complete block, 2-period crossover pilot trial. The study will assess target engagement of the ventral striatum after LIFU in patients with alcohol use disorder using resting state and task-based functional magnetic resonance imaging (fMRI).

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.